Novel predictors of immune checkpoint inhibitor response and prognosis in advanced non-small-cell lung cancer with bone metastasis.
Yohei AsanoNorio YamamotoSatoru DemuraKatsuhiro HayashiAkihiko TakeuchiSatoshi KatoShinji MiwaKentaro IgarashiTakashi HiguchiYuta TaniguchiSei MorinagaTakashi SoneMiho OkudaIsao MatsumotoSeiji YanoHiroyuki TsuchiyaPublished in: Cancer medicine (2023)
This study identified some novel predictors for favorable therapeutic response and prognosis in advanced NSCLC patients with bone metastases undergoing ICI treatment. Pretreatment NLR less than 2.1 can be considered the most important predictor.